Zhao Hong 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Aug 16, 2017
Insider Transaction Report
Form 4
Zhao Hong
CEO, China Operations
Transactions
- Sale
Common Stock
2017-08-16$11.00/sh−30,000$330,000→ 0 total - Exercise/Conversion
Restricted Stock Unit
2017-08-15−30,000→ 127,000 total→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2017-08-15+30,000→ 30,000 total
Footnotes (3)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.